OA and the metabolic syndrome are recognized as the low-grade inflammatory condition with elevations in systemic inflammatory mediators such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF) [29]. The gene discussed is TNF; the disease is metabolic syndrome.